Delivery Order SPE2DB22D9239-SPE2DB24FDL28

Award Date 7/31/24
Potential Completion Date 8/21/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $78,783.00 firm fixed-price delivery order is for the supply of 4556749427 PERJETA 420 MG/14 ML VIAL 14ML to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $42,549.60 firm-fixed-price delivery order is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a medication used in cancer treatment. The award is under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain division, which allows the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,254.96 firm fixed-price contract is for the procurement of PERJETA 420 MG/14 ML VIAL 14ML, a specialty oncology drug. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $36,458.16 firm fixed-price delivery order is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a prescription drug product. The contract has an ultimate completion date of June 20, 2025 and is not designated as a set-aside. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,764.88 firm fixed-price delivery order is for the supply of Perjeta 420 mg/14 ml vial (14 ml) to fulfill the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
The U.S. Defense Logistics Agency (DLA) awarded a $4,254.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 4564220840 - PERJETA 420 MG/14 ML VIAL 14ML, a pharmaceutical product. This order is part of a larger indefinite delivery vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, with a ceiling value of up to $4,999,999 through the end of 2025. This IDV enables DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 firm fixed-price delivery order is for the supply of Perjeta 420 mg/14 ml vials to fulfill the medical needs of U.S. military personnel and their dependents. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,254.96 award is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology drug, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $17,019.84 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563691587 PERJETA 420 MG/14 ML VIAL 14ML pharmaceutical products. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, which has a potential value of up to $4,999,999 and enables the agency to...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,343.62 contract was awarded by the Defense Logistics Agency (DLA) for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a specialty oncology medication. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDL28
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 firm fixed-price delivery order is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including common medications as well as specialized drugs and medical supplies, to fulfill the diverse medical requirements of Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide array of pharmaceutical products and medical consumables to support military personnel and their dependents.

Generated 10/30/24, 9:36 AM